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Abstract The importance of E-cadherin protein in the establish- 
ment and maintenance of homotypic contacts in epithelial cells 
has already been determined. We report here that the association 
of E-cadberin to cytoskeleton, required for the functionality of 
this protein, increases progressively after seeding; in HT-29 M6 
cells 4-5 days were required for detecting most of E-cadherin in 
the Triton X-100-insoluble (cytoskeleton-associated) fraction. 
The phorbol ester TPA differently affected E-cadherin levels in 
HT-29 M6 cells; at day 2-3, when most E-cadherin was found 
not-associated to the cytoskeleton, very important decreases 
(90%) in the total levels of this protein were detected as soon as 
6 h after the addition of this compound. However, on later days 
(day 5), the predominant effect by 6 h was a translocation from 
the Triton-insoluble to the soluble fraction. The E-cadherin-asso- 
ciated proteins a-catenin and l~l-cateuin were not significantly 
affected by treatment with TPA. 
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1. Introduction 
Cadherins are a family of transmembrane proteins impli- 
cated in calcium-dependent cell-cell adhesion. The activity of 
these proteins has been reported o be necessary for the correct 
development of the embryo, as well as the morphogenesis of 
several tissues [1,2]. One of the members of this family, E- 
cadherin is a protein that plays  main role in the establishment 
of cell-cell adhesion in epithelial cells [3,4]. Downregulation of 
E-cadherin in transformed cell lines has been associated with 
de-differentiation and acquisition f the ability to invade, sug- 
gesting a possible role of this protein as a tumor supressor [5], 
The activity of E-cadherin requires interactions at both sides 
of the membrane. On the extracellular side, different domains 
have been implicated in Ca 2+ binding and homophilic inter- 
actions [2]. On the cytoplasmic side, it has been shown that 
E-cadherin binds several proteins: 0~-catenin, fl-catenin, plako- 
globin and p 120, involved in linking E-cadherin to the cytoskel- 
eton and modulating its activity [6,7]. From these proteins, 
interaction with ~-catenin has been shown to be sufficient to 
promote association of E-cadherin to the cytoskeleton and to 
induce polarized cell-cell asociation i  several lines of dispersed 
cells [8,9]. 
The phorbol ester 12-O-tetradecanoylphorbol-13-acetate 
(TPA) a potent and specific activator of protein kinase C 
(PK-C) [10] promotes a remarkable change in the phenotype 
of HT-29 M6 intestinal cells. TPA induces the scattering of 
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HT-29 M6 colonies; it decreases cell-cell aggregation and en- 
hances the cellular attachment to matrix substrates (collagen, 
laminin) [11]. The reported ecrease in cell-to-cell adhesion was 
accompanied by a fast change in the cellular localization of 
E-cadherin and a slower downregulation f this protein, as it 
was evidenced by immunofluorescence [11]. In this article we 
have studied with more detail the effects of TPA over the 
distribution and levels of E-cadherin in HT-29 M6 by cell frac- 
tionation and immunoblotting. 
2. Materials and methods 
2.1. Cell culture 
The HT-29 M6 cell line, a subpopulation of the HT-29 cells, isolated 
by selection with 10 -6 methotrexate [12,13], was supplied by Dr. Alain 
Zweibaum (INSERM, Villejuif, France). C lls were seeded at 2 × 10 4 
cells/cm 2 and cultured in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) (Gibco) in 
a humidified atmosphere of 5% CO2/95% air; culture media w s 
changed every other day to void nutrient depletion. Cells were used 
between passages 40 and 60. 
2.2. Cell extraction and immunoblotting 
Soluble and cytoskeletal fractions were prepared essentially as de- 
scribed by Nelson and coworkers [14]. Cells were rinsed in TBS plus 
1 mM CaCIz and homogenized in CSK buffer (50 mM NaC1, 10 mM 
PIPES, pH 6.8, 3 mM MgCI> 0.5% Triton X-100, 300 mM sucrose, 
1 mM phenylmethyl sulphonyl fluoride, 10/lg/ml eupeptin, 1 mM 
orthovanadate, 20/aM phenylarsine oxide) for l0 min at 4°C with 
gentle rocking. After centrifugation in a microfuge for l0 rain at 4°C 
supernatant constituted the Triton-soluble fraction. Pellet was tritu- 
rated in SDS buffer (20 mM Tris, pH 7.5, 5 mM EDTA, 2.5 mM 
EGTA, 1% SDS) and boiled at 100°C for 10 min. After centrifugation 
for l0 min in a microfuge, supernatant constituted the Triton-insoluble 
fraction. This fraction usually contained 5-fold less protein than the 
Triton-soluble fraction. Cell fractions were separated by SDS-PAGE, 
transferred electrophoretically to nitrocellulose and incubated for 1 h 
with mAbs anti-E-cadherin HECD-1, a kind gift of Dr. A. Cano 
Universidad Aut6noma de Madrid), anti-ct-catenin or anti-fl-catenin 
(both from Transduction Labs, Lexington, KY) at a concentration f 
1 ~tg/ml. After washing, membranes were incubated with peroxidase- 
conjugated goat anti-mouse antibodies (Dakopatts, Copenhagen, Den- 
mark), and reacting antigens were visualized using ECL detection rea- 
gents (Amersham). 
3. Results 
3.1. Association to cytoskeleton of E-cadherin depends on the 
day of culture 
HT-29 M6 cells grow in compact colonies that after conflu- 
ence originate a cell monolayer with well-defined tight contacts. 
E-cadherin-mediated c ll adhesion constitutes the first step in 
order to produce these structures. It has been reported that 
functionality of E-cadherin requires its association to the cy- 
toskeleton [15]; therefore soluble and cytoskeletal fractions 
were prepared following the method of Nelson and coworkers 
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Fig. I. Association to cytoskeleton fE-cadherin in HT-29 M6 progres- 
sively increases after seeding. Cells were seeded as described in section 
2 and cultured in DME medium supplemented with FBS (10%) for the 
indicated days (2 7). Cell extracts were prepared and E-cadherin levels 
were determined by Western blot with mAb HECD-I. 35 ¢tg of the 
Triton-soluble (S) and 7 pg of the Triton-insoluble (I) fractions were 
analyzed in this study. Only a major band of 120 kDa, corresponding 
to E-cadherin, was detected with is antibody. 
[14] from HT-29 M6 cells at different imes after seeding. This 
method, used succesfully in MDCK cells [14,16], is based in the 
high resistance to solubilization in nonionic detergents that 
present cytoskeleton-associated proteins. As shown in Fig. 1, 
A 
d2 
at day 2 after seeding most of E-cadherin was detected in the 
Triton-soluble fraction, reflecting the fact of a very low associ- 
ation to the cytoskeleton (lower than 10-15% in three different 
experiments). The proportion of E-cadherin present in the Tri- 
ton-insoluble fraction increased slowly after seeding, reaching 
a value of 80-90% at day 7 (four different experiments). Our 
experiments indicate that in HT-29 M6 cells 4-5 days are re- 
quired for E-cadherin to be able to associate to the cytoskele- 
ton. No significant changes in the total cellular amount of 
E-cadherin were detected at the different times studied. 
3.2. TPA affects E-cadherin distribution and cellular levels 
We have previously reported that short treatments (2-3 h) 
with the phorbol ester TPA induce phenotypic changes in 
HT-29 M6 cultures, characterized by the scattering of the cell 
colonies and the acquisition of a fibroblast-like morphology 
[11]. In this study, we observed a change in the distribution of 
E-cadherin by immunofluorescence, with a loss of reactivity in 
the cellular membrane. Levels and distribution of cadherin 
after addition of TPA were studied in greater detail and repre- 
sentative xperiments are shown in Fig. 2. A kinetic study with 
cells at different days after seeding reflected a combined effect 
of the phorbol ester both on total levels and distribution of this 
protein. At day 2, when more than 90% of E-cadherin was 
found not-associated to the cytoskeleton, a rapid downregula- 
tion of this molecule was observed (85% by 6 h). Similar results 
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Fig. 2. TPA affects the cellular levels and the association to cytoskeleton of E-cadherin. Cells were seeded and grown as described for 2 (d2), 3 (d3) 
or 5 (d5) days; TPA (200 nM) was added and extracts were prepared at the indicated times after the addition of this phorbol ester. (A) E-Cadherin 
was analyzed by Western blot as described in the Triton-soluble (S) and insoluble (I) fractions. (B) Autoradiograms were scanned and E-cadherin 
levels were represented atdifferent imes after addition of TPA. [] = Triton-soluble fraction; * = Triton-insoluble fraction; • = total cellular levels. 
An arbitrary value of 100 was assigned to the value of E-cadherin present in the Triton-soluble fraction before the addition of TPA. 
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Fig. 3. TPA does not modify the cellular levels or the distribution of cz and fl-catenins. (A) Same extracts obtained from cells at day 3 after seeding 
were analyzed by Western blot using mAbs against cz- or fl-catenin. Only two bands of molecular weights 105 kDa (corresponding to cz-catenin) and 
95 kDa (corresponding to fl-catenin) were detected with these antibodies. (B) Autoradiograms were scanned nd total cellular levels of E-cadherin 
(taken from Fig. 2) (m), c~-catenin (*), and fl-catenin (A) were represented at ifferent times after addition of TPA. A value of 100 was arbitrarily 
taken as the initial amount of these three proteins. 
were obtained at day 3 with a slight difference; the disappear- 
ance of insoluble E-cadherin was observed before any decrease 
of the soluble protein, suggesting a possible translocation of
E-cadherin from one fraction to the other. This translocation 
was clearly observed at day 5, where 60% of the protein was 
detected in the insoluble fraction; after 4 h of incubation the 
amount of insoluble E-cadherin had been decreased by 37%. In 
this case no significant decreases in the total amount of E- 
cadherin were detected by 6 h; after 15 h fell by 30-50% (three 
experiments) (not shown). 
3.3. Downregulation of E-cadherin by TPA is not accompanied 
by changes in the levels or distribution of cz- or fl-catenin 
Catenins are proteins that bind to E-cadherin and are needed 
for its activity [6]. Binding to ~-catenin has been demonstrated 
to be sufficient to link E-cadherin to the cytoskeleton [8,9]; the 
role of fl-catenin has not been established yet although it has 
been recently proposed that its binding could reduce E-cad- 
herin activity [17]. Using mAbs pecific for these proteins we 
determined if the changes induced by TPA in the levels of 
E-cadherin were accompanied by alterations of these proteins. 
Fig. 3 shows that the levels of ~z- or fl-catenin did not change 
significantly, either in the Triton-soluble or insoluble fraction, 
after addition of TPA, contrarily to E-cadherin. The distribu- 
tion of these two proteins was not affected either by this treat- 
ment; the proportion of cz- or fl-catenin in the cytoskeletal 
fraction (32 and 40%, respectively at day 3) remained unaltered 
after 6 hours of incubation with TPA. 
4. Discussion 
In this article we demonstrate hat TPA modifies the E-cad- 
herin levels in HT-2 M6 cells. The effect of this compound is
dependent on the initial localization of E-cadherin; when the 
protein is soluble (early cultures) the phorbol ester causes a 
rapid depletion (80 90% at 6 h); however, when it is associated 
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to the cytoskeleton (late cultures) the most evident effect is the 
translocation to the soluble fraction and, only later, does a 
partial downregulation occur. In addition to these kinetic dif- 
ferences, the loss in E-cadherin was more complete in early than 
in late cultures of HT-29 M6 cells. 
Very few examples of downmodulation of E-cadherin have 
been reported so far. It has been shown that E-cadherin is 
regulated by the ERBB2 proto-oncogene [18], an homologous 
of EGF receptor kinase. Overexpression of ERBB2 results in 
the transcriptional inhibition of the E-cadherin gene; inversely, 
addition to cells overexpressing ERBB2 of an antibody that 
blocks ERBB2 phosphorylation and signal transduction 
through the GRB2/Sem5 protein produces an increase in 
E-cadherin transcription [18]. These evidences point to a signal 
transduction pathway involving tyrosine kinases as an impor- 
tant element in the control of the levels of E-cadherin. We show 
in this article that the cellular content of this protein can also 
be controlled by another pathway initiated by activation of 
PK-C. It is likely that both pathways cross-talk, since we (A.S. 
and A.G.H., unpublished observations) and others [19] have 
shown stimulation of the tyrosine kinase c-src by PK-C activa- 
tors in different HT-29 subpopulations. Additional evidence 
from our lab, showing increased levels of E-cadherin in cells 
treated with the tyrosine kinase inhibitor herbimycin (A.S. and 
A.G.H., unpublished observations), further support an i volve- 
ment of these protein kinases in the control of E-cadherin levels 
in HT-29 cells. 
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